Ngan HY - Search Results

1

Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer.

Huang FY, Chiu PM, Tam KF, Kwok YK, Lau ET, Tang MH, Ng TY, Liu VW, Cheung AN, Ngan HY. Huang FY, et al. Among authors: ngan hy. Gynecol Oncol. 2006 Oct;103(1):219-25. doi: 10.1016/j.ygyno.2006.02.028. Epub 2006 Apr 3. Gynecol Oncol. 2006. PMID: 16595147

2

Rudimentary uterine horn with adenomyosis and pelvic endometriosis in a 23-year-old girl.

Tang LC, Ngan HY, Tang MH. Tang LC, et al. Among authors: ngan hy. J Adolesc Health Care. 1986 Jul;7(4):265-7. doi: 10.1016/s0197-0070(86)80020-1. J Adolesc Health Care. 1986. PMID: 3522512

3

Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease: correlation with mdm2, proliferation index, and clinicopathologic parameters.

Cheung AN, Shen DH, Khoo US, Chiu MP, Tin VP, Chung LP, Ngan HY. Cheung AN, et al. Among authors: ngan hy. Int J Gynecol Cancer. 1999 Mar;9(2):123-130. doi: 10.1046/j.1525-1438.1999.09904.x. Int J Gynecol Cancer. 1999. PMID: 11240753

4

Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?

Chan YM, Ng TY, Ngan HY, Wong LC. Chan YM, et al. Among authors: ngan hy. Gynecol Oncol. 2002 Jan;84(1):7-11. doi: 10.1006/gyno.2001.6497. Gynecol Oncol. 2002. PMID: 11748969

5

Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population.

Khoo US, Chan KY, Cheung AN, Xue WC, Shen DH, Fung KY, Ngan HY, Choy KW, Pang CP, Poon CS, Poon AY, Ozcelik H. Khoo US, et al. Among authors: ngan hy. Hum Mutat. 2002 Mar;19(3):307-8. doi: 10.1002/humu.9015. Hum Mutat. 2002. PMID: 11857749 Free article.

6

Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.

Xue WC, Guan XY, Ngan HY, Shen DH, Khoo US, Cheung AN. Xue WC, et al. Among authors: ngan hy. Cancer. 2002 Apr 15;94(8):2288-94. doi: 10.1002/cncr.10424. Cancer. 2002. PMID: 12001129 Free article.

7

Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening.

Ngan HY, Cheung AN, Liu SS, Liu KL, Tsao SW. Ngan HY, et al. Tumour Biol. 2002 Mar-Apr;23(2):87-92. doi: 10.1159/000059710. Tumour Biol. 2002. PMID: 12065846

8

Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.

Chan KY, Ozçelik H, Cheung AN, Ngan HY, Khoo US. Chan KY, et al. Among authors: ngan hy. Cancer Res. 2002 Jul 15;62(14):4151-6. Cancer Res. 2002. PMID: 12124354

9

Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract.

Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC, Ngan HY. Ip SM, et al. Among authors: ngan hy. Gynecol Oncol. 2002 Oct;87(1):104-11. doi: 10.1006/gyno.2002.6784. Gynecol Oncol. 2002. PMID: 12468350

10

Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study.

Chan YM, Ng TY, Ngan HY, Wong LC. Chan YM, et al. Among authors: ngan hy. Gynecol Oncol. 2003 Jan;88(1):9-16. doi: 10.1006/gyno.2002.6849. Gynecol Oncol. 2003. PMID: 12504620 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters